Published Sep 11, 2026, 4:54 PM ET · Updated 2 months ago · 2 sources
AstraZeneca Says Breast Cancer Pill Fails in Key Study
bloomberg
·
Original Report
AstraZeneca Plc’s breast cancer pill failed to delay disease progression more than the standard treatment in a late-stage trial, results that could dampen optimism around the medicine.